Hanne Leth Hillman
Président chez The Danish Investor Relations Society
Profil
Hanne Leth Hillman is currently the Co-Chairman at The Danish Investor Relations Society and the Chief Financial Officer at Nanovi Radiotherapy A.
Previously, she held positions such as VP, Director-Investor Relations & Capital Market at NTG Nordic Transport Group A in 2009-2010, Analyst at Gudme Raaschou Bank A in 2004, and Senior VP-Investor Relations & Communications at Zealand Pharma A in 2015-2016.
Ms. Hillman obtained an MBA from the University of Aarhus.
Postes actifs de Hanne Leth Hillman
| Sociétés | Poste | Début |
|---|---|---|
| The Danish Investor Relations Society | Président | - |
Nanovi Radiotherapy A/S
 Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Directeur Financier/CFO | 01/05/2017 |
Anciens postes connus de Hanne Leth Hillman
| Sociétés | Poste | Fin |
|---|---|---|
| BRAIN+ A/S | Directeur Financier/CFO | 01/01/2024 |
| ZEALAND PHARMA A/S | Investor Relations Contact | 01/10/2016 |
| Gudme Raaschou Bank A/S | Analyst-Equity | 05/11/2004 |
| NTG NORDIC TRANSPORT GROUP A/S | Investor Relations Contact | - |
Formation de Hanne Leth Hillman
| University of Aarhus | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| ZEALAND PHARMA A/S | Health Technology |
| BRAIN+ A/S | Technology Services |
| Entreprise privées | 3 |
|---|---|
| Gudme Raaschou Bank A/S | Finance |
| The Danish Investor Relations Society | |
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
